Ocean Biomedical (NASDAQ: OCEA) Announces 70% Increase in Price Target by EF Hutton from $10 to $17 on New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 Antibody
May 01, 2023 08:01 ET
|
Ocean Biomedical, Inc.
Providence, RI, May 01, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development and commercialization of scientifically compelling...
AnaChart is Set to Democratize the Equity Research Market by Identifying the Best Stock Analysts for Each Company
June 07, 2022 11:30 ET
|
AnaChart
NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) -- AnaChart, an innovative Fintech startup company, is exiting its stealth mode with an intent to disrupt the equity research industry. AnaChart democratizes...
Marble Arch Research, Inc. Initiates Research Coverage of Healixa Inc.
May 17, 2021 09:56 ET
|
Emerald Organic Products Inc.
Holbrook, New York, May 17, 2021 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) (“Healixa”, or the “Company”), a healthcare technology company delivering seamless and instant virtual care from...